Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BON-001 Phase III study in nausea and vomiting of pregnancy
jRCT2031260483Phase 3Recruiting
- Sponsor
- Mochida Pharmaceutical Co., Ltd.
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in nausea and vomiting of pregnancy (NVP) comparing BON-001 with Placebo (2 arms). Primary endpoint: AUC of PUQE-24 scores from Day 3 through Day 15. Started Oct 2026; status: recruiting.
02
Drugs
doxylamine succinate + pyridoxine hydrochloride
03
Conditions
nausea and vomiting of pregnancy (NVP)
Beyond the preview
Go deeper on jRCT2031260483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031260483.